Eligible patients had COPD, were ages 40 or older, and were new initiators of these inhalers from 2021 to 2023. They were ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...

People who have asthma or bronchitis or other lung conditions often take prescribed medications through an inhaler—a device that releases the medication in a spray so that it reaches its target—the ...

The prevalence of COPD rises with age ... recommendations on improving device selection to promote competent inhaler use and medication adherence.

Israel-based Teva said the system conveys information to patients, who can use the product ... pulmonary disease (COPD). Teva noted it is the first and only digital rescue inhaler indicated ...

Although the 1990s saw a switch from MDIs using ozone-depleting chlorofluorocarbons ... Starting with the Brestri Aerosphere COPD inhaler (pending regulatory approval), AstraZeneca intends to ...

Bronchodilators Don't Improve Smoking-Related Respiratory Symptoms in People Without COPD Sep. 5, 2022 — Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the ...

Publishing two complementary papers in Radiology and JHLT Open, the team explained how they use a special gas, called ...

The odds are high you’ve had a cough before in your life, but each time can throw you for a loop. Even though you’ve been ...

Albert Einstein once said, “Two things are infinite: the universe and human stupidity; and I’m not sure about the universe.” ...

While some manufacturers are using new forms of drug delivery, such as dry-powder inhalers, others have developed MDIs with propellants that are less deleterious to the environment. Two such ...